Osteoporosis

Osteoporosis is the disease of the bone that leads to an increased risk of fracture.
In osteoporosis the bone mineral density (BMD) is reduced, bone microarchitecture is disrupted, and the amount and variety of proteins in bone is altered.

Osteoporosis in women is defined by the World Health Organization (WHO) as a bone mineral density of 2.5 with standard deviations below peak bone mass (20-year-old healthy female average) as measured by DXA; the term "established osteoporosis" includes the presence of a fragility fracture.

Osteoporosis is most common in women after menopause, when it is called postmenopausal osteoporosis. It may also develop in men and may occur in the presence of particular hormonal disorders (for example, testosterone deficiency, Vitamin D deficiency) and other chronic diseases or as a result of medications, specifically glucocorticoids, when the disease is called steroid- or glucocorticoid-induced osteoporosis (SIOP or GIOP).

Given its influence in the risk of fragility fractures, osteoporosis may significantly affect life expectancy and quality of life.

We have diagnosed the large number of patients with osteoporosis in the middle and even young age group.

We believe that widespread Vitamin D deficiency along with other nutritional deficiencies play the major role in the early onset of bone loss.

We believe that bone loss is a side effect of taking certain medications, and it is underestimated. For example: 28 years old female who was taking diuretics ( ‘water pills”) for about 8 years was diagnosed with advanced osteoporosis.

We found a few cases of Osteoporosis in young women with irregular or absent periods due to abnormally low levels of female hormones.

We also found a lot of new cases of Male Osteoporosis.

Low Testosterone level along with Vitamin D deficiency and smoking may provoke developing of Osteoporosis in men as early as in their 20 s.

The good news is: Bone can be rebuilt.

The body starts reconstructing the bone tissue after offending factors are eliminated and nutritional and hormonal deficiencies are corrected.  We monitor this process not only by performing Bone Densitometry testing but also by doing a series of Bone Resorption Assessments (link to the appropriate page under “Diagnostic Methods”). It aids in directing and tuning the individually designed treatment regiment.
 
We have a number of cases when Osteoporosis was successfully treated with this complex approach.